Potential FDA Peptide Reclassification 2026 What It Means for Patients Beverly Hills Rejuvenation Center 2026 FDA Peptide Reclassification Purefico Medspa and Therapy The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be Upcoming FDA APPROVALS : March April 2026 . : r biotech_stocks FDA Peptide Reclassification 2026: What Researchers Want